GS

Gayatriben Shah

Active Director Director DIN 09436672
DIN 09436672 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Dec 2021
Shareholding value •••• Premium profile

About Gayatriben Shah

Data last updated:

Gayatriben Shah is a Director at Advanov Pharma Private Limited (since 2023) and Director at Jewal Pharmaceutical Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹22.69 Cr; the largest is Advanov Pharma Private Limited at ₹22.68 Cr (FY 2024).

DIN 09436672
Primary Designation Director
Industry Pharma
First Appointment 15 Dec 2021
Oldest Company Age 9 yrs
Largest company Advanov Pharma Private Limited · ₹22.68 Cr (FY 2024)
Combined revenue ₹22.69 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advanov Pharma Private Limited U74999GJ2017PTC097840
Director06 Feb 20232017₹22.68 Cr (FY 2024)Active
Jewal Pharmaceutical Private Limited U24290GJ2021PTC128005
Director15 Dec 20212021₹32,000 (FY 2025)Active

Board colleagues of Gayatriben Shah

Directorship timeline

Open interactive timeline →
Advanov Pharma Private Limited
Jewal Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Gayatriben Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayatriben Shah

Gayatriben Shah currently holds 2 directorships: Advanov Pharma Private Limited (Director, since 06 Feb 2023, revenue ₹22.68 Cr (FY 2024)); Jewal Pharmaceutical Private Limited (Director, since 15 Dec 2021, revenue ₹32,000 (FY 2025)).

Gayatriben Shah was first appointed on 15 Dec 2021 as Director at Jewal Pharmaceutical Private Limited. The most recent appointment on record is 06 Feb 2023 at Advanov Pharma Private Limited.

The 2 current companies of Gayatriben Shah that report revenue have a combined latest revenue of ₹22.69 Cr: Advanov Pharma Private Limited ₹22.68 Cr (FY 2024); Jewal Pharmaceutical Private Limited ₹32,000 (FY 2025).

The current boards of Gayatriben Shah's companies include Hemalkumar Rashmikant Shah (Advanov Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available